Electrical spinal stimulation can reduce toxic TDP-43 protein aggregates in preclinical ALS mouse models, a study reports.
New research in human neurons shows that the ALS-linked RNA-binding protein TDP-43 is transported along axons by a flexible ...
In a study published in Molecular Therapy Advances a team of researchers led by Professor Haruhisa Inoue (Center for iPS Cell Research and Application, Kyoto University) and Professor Yuishin Izumi ...
A Norwegian family study reveals that muscle wasting in NHP2-related dyskeratosis congenita is driven by neurogenic ...
PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive treatment for Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s disease), ...
In a race against time, an infant aged 7 months and 23 days received gene replacement therapy for Spinal Muscular Atrophy ...
Neural stem cells are multipotent adult stem cells present in the adult central nervous system that can self-renew, and give rise to new neurons and supporting cells called glial cells. Activation of ...
A team of researchers led by Professor Haruhisa Inoue (Center for iPS Cell Research and Application, Kyoto University) and Professor Yuishin Izumi (Tokushima University) demonstrated that adenine base ...
A novel treatment for amyotrophic lateral sclerosis (ALS) caused by mutations in a specific gene called CHCHD10 showed ...
Creatine, a popular dietary supplement, prevented brain inflammation, nerve cell damage, and disrupted electrical activity in ...
A research team has found that pharmacologically enhancing neuronal chloride regulation improves locomotor performance and ...
New research suggests the brain develops from two separate groups of early cells, one forming the forebrain and midbrain and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results